| SC 13G/A | 2006-02-08 | ATLAS VENTURE FUND V LP | ALNYLAM PHARMACEUTICALS, INC. | 1,337,464 | 5.0% | EDGAR |
| SC 13G | 2005-10-24 | NOVARTIS AG | ALNYLAM PHARMACEUTICALS, INC. | 5,267,865 | 19.9% | EDGAR |
| SC 13G | 2005-10-11 | FMR CORP | ALNYLAM PHARMACEUTICALS, INC. | 2,756,087 | 13.0% | EDGAR |
| SC 13G | 2005-04-15 | MERCK & CO INC | ALNYLAM PHARMACEUTICALS, INC. | 1,236,588 | 5.9% | EDGAR |
| SC 13G/A | 2005-04-11 | FMR CORP | ALNYLAM PHARMACEUTICALS, INC. | 100 | 0.0% | EDGAR |
| SC 13G/A | 2005-02-23 | Abingworth Management LTD | ALNYLAM PHARMACEUTICALS, INC. | 2,343,163 | 11.7% | EDGAR |
| SC 13G/A | 2005-02-14 | ARCH VENTURE FUND V LP | ALNYLAM PHARMACEUTICALS, INC. | 1,956,527 | 9.4% | EDGAR |
| SC 13G/A | 2005-02-14 | POLARIS VENTURE PARTNERS III LP | ALNYLAM PHARMACEUTICALS, INC. | 2,313,914 | 11.1% | EDGAR |
| SC 13G | 2005-02-14 | FMR CORP | ALNYLAM PHARMACEUTICALS, INC. | 1,130,510 | 5.6% | EDGAR |
| SC 13G | 2005-02-09 | ATLAS VENTURE FUND V LP | ALNYLAM PHARMACEUTICALS, INC. | 2,006,195 | 10.0% | EDGAR |
| SC 13D | 2004-07-21 | CHP II LP | ALNYLAM PHARMACEUTICALS, INC. | 2,091,870 | 10.4% | EDGAR |
| SC 13G | 2004-06-14 | Abingworth Management LTD | ALNYLAM PHARMACEUTICALS INC | 2,343,159 | 12.2% | EDGAR |
| SC 13G | 2004-06-10 | ARCH VENTURE FUND V LP | ALNYLAM PHARMACEUTICALS INC | 2,006,197 | 10.4% | EDGAR |
| SC 13G | 2004-06-07 | POLARIS VENTURE MANAGEMENT CO III LLC | ALNYLAM PHARMACEUTICALS INC | 2,710,141 | 14.1% | EDGAR |